Drug Profile
Tigecycline - Accord Healthcare
Alternative Names: Tigecycline AccordLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Accord Healthcare
- Class Antibacterials; Glycylcyclines; Small molecules
- Mechanism of Action Mitochondrial protein inhibitors; Protein 30S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Community-acquired pneumonia; Intra-abdominal infections; Skin and soft tissue infections
Most Recent Events
- 27 Mar 2018 Chemical structure information added
- 06 Feb 2018 Registered for Skin and soft tissue infections, Intra-abdominal infections (Complicated), Community-acquired pneumonia in USA (IV)
- 29 Jul 2016 Pfizer initiates litigation against Accord Healthcare over NDA submission for tigecycline in the US